SEC Form 4 · accession 0001144204-18-029521

Prestige Consumer Healthcare Inc. · PBH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, Science and Technology

Period of report

May 15, 2018

Accepted (ET)

May 17, 2018 · 4:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001295947

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, par value $0.01 per share	May 15, 2018	M	10,879	$29.94	A	21,960	D
Common Stock, par value $0.01 per share	May 15, 2018	M	9,649	$33.50	A	31,609	D
Common Stock, par value $0.01 per share^F1	May 15, 2018	S	20,528	$36.91	D	11,081	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Options (rights to buy)^F2	$29.94	May 15, 2018	M	10,879	D	—	May 14, 2023	Common Stock	10,879	0	D
Employee Stock Options (rights to buy)^F3	$33.50	May 15, 2018	M	9,649	D	—	May 12, 2024	Common Stock	9,649	0	D

F1The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a sale order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. This transaction was executed in multiple trades at prices ranging from $36.21 to $37.80. The price reported above reflects the weighted average sale price.
F2The options vested in the three installments as followed: 3,627 shares on May 14, 2014 and 3,626 shares each on May 14, 2015 and 2016.
F3The options vested in three installments as followed: 3,217 shares on May 12, 2015 and 3,216 shares each on May 12, 2016 and 2017.